Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB26FV5TG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,701
Award facts
- Contract value 100% obligated
- $14,700.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,700.92 to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 mL pen injectors on October 16, 2025, with an ultimate completion date of October 17, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables supply of a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills pharmaceutical delivery orders through the DLA's Medical Supply Chain. Wegovy is a GLP-1 receptor agonist indicated for chronic weight management, and this delivery order supports federal healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract reflects AmerisourceBergen's established capability to meet competitive federal procurement requirements through its expansive portfolio covering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FV5TG?
SPE2DB26FV5TG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FV5TG worth?
The government has obligated $14,701 on SPE2DB26FV5TG.
Is contract SPE2DB26FV5TG an order under another contract?
Yes. SPE2DB26FV5TG is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB26FV5TG competed?
The extent of competition for SPE2DB26FV5TG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award